GENEIUS BIOTECHNOLOGY INVESTMENTS LLC has a total of 11 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Republic of Korea, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are NANJING KEYGEN BIOTECH CO LTD, CAPRICOR INC and ADVANCED REGEN MEDICAL TECH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Singapore | 2 | |
#5 | Taiwan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | IT methods for management |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Data processing systems | |
#5 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Slanetz Alfred E | 11 |
Publication | Filing date | Title |
---|---|---|
SG10201604236RA | Modulated Immunodominance Therapy | |
EP2656289A1 | Clinical outcome-dependent medical intervention cost reimbursement system |